Restrictive dieting, whether part of a commercial weight plan or associated with GLP-1 medication usage, can sometimes lead to nutrient gaps that undermine energy and overall well-being
Esposito A, Valentino MR, Bruzzese D, Bocchino M, Ponticiello A, Stanziola A, Sanduzzi A (2016) Effect of carbocisteine in prevention of exacerbation of chronic obstructive pulmonary disease (CAPRI study): an observational study
Diabetes Obes Metab 19:16691680 Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial
Chang 2011)
The equivalence margin ( 2 percentage points) was selected as a pragmatic threshold for between-treatment differences, rather than an absolute clinical target
These risks make medical supervision essential throughout your treatment journey